Back to search

The value of comparative bioavailability studies of marketed drugs in drug control. An example with erythromycin stearate.

Venho Vm, Palva Es, K Konno, E Stenfors
PubMed

Data up to Jan 2025

Published1987
Citations5
References0
Fields
ChemistryMedicineMaterials sciencePharmacologyChromatographyBiochemistry

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
The value of comparative bioavailability studies of marketed drugs in drug control. An… (1987) – PubMed | Metascience Observatory Explorer